Are you Dr. Goldberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4501 X St
Sacramento, CA 95817Phone+1 916-734-8252
Summary
- Dr. Zelanna Goldberg, MD is a radiation oncologist in Sacramento, California. She is currently licensed to practice medicine in California.
Education & Training
University of Toronto Faculty of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1998 - 2026- American Board of Radiology Radiation Oncology
Clinical Trials
- Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer Start of enrollment: 2003 Sep 01
- Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab Start of enrollment: 2006 Oct 01
Publications & Presentations
PubMed
- 47 citationsCombined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non–Small Cell Lung Cancer: Results of a Phase I StudyPasi A. Jänne, Alice T. Shaw, D. Ross Camidge, Giuseppe Giaccone, S. Martin Shreeve
Journal of Thoracic Oncology. 2016-05-01 - 17 citationsEffect of food or proton pump inhibitor treatment on the bioavailability of dacomitinib in healthy volunteersAna Ruiz-Garcia, Joanna C. Masters, Laure Mendes da Costa, Robert R. LaBadie, Yali Liang
Journal of Clinical Pharmacology. 2016-02-01 - 231 citationsTargeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or a...Mark G. Kris, D.R. Camidge, Giuseppe Giaccone, Toyoaki Hida, Bob T. Li
Annals of Oncology. 2015-07-01
Press Mentions
Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial ResultsAugust 10th, 2021- Alpine Immune Sciences Appoints Zelanna Goldberg, M.D., M.A.S. As Chief Medical OfficerJune 2nd, 2021
